Reports

In the financial year 2018/19, we achieved consolidated sales of CHF 453.8 million (previous year: CHF 466.1 million). Compared to the previous year, there was only a slight decline in sales of only 2.7 % despite the termination of the mylife™ OmniPod® business. In continuing operations, we achieved a sales growth of CHF 68.4 million, which represents an increase of 24 %.

The operating result (EBIT) amounted to CHF 73.3 million (previous year: CHF 61.1 million). This includes CHF 49.8 million in revenue and profit-related compensation from Insulet Corp. for the development of the European distribution structure for the Omnipod®. Profitability at EBIT level thus amounted to 16.2 % (previous year: 13.1 %). Net profit for the 2018/19 financial year amounts to CHF 60.1 million (previous year: CHF 52.1 million).